Related Experiment Video
Updated: Jun 28, 2025

Ultrasound Assessment of Endothelial Function: A Technical Guideline of the Flow-mediated Dilation Test
Published on: April 27, 2016
Endothelial dysfunction in vascular complications of diabetes: a comprehensive review of mechanisms and implications
Dong-Rong Yang1,2, Meng-Yan Wang2, Cheng-Lin Zhang2
1Department of Endocrinology and Metabolism, Shenzhen University General Hospital, Shenzhen, Guangdong, China.
Insights
Diabetic vascular complications stem from endothelial dysfunction, impacting quality of life. This review explores mechanisms and pharmacotherapies for diabetic endothelial dysfunction and related vascular diseases.
Area of Science:
- Vascular Biology
- Endocrinology
- Pharmacology
Background:
- Diabetic vascular complications significantly impact patient quality of life and mortality.
- These complications arise from endothelial dysfunction driven by hyperglycemia, hypertension, and dyslipidemia.
- Endothelial dysfunction manifests as inflammation, oxidative stress, reduced nitric oxide, and cellular changes.
Purpose of the Study:
- To elucidate the mechanisms of endothelial dysfunction in diabetes.
- To review vascular complications associated with diabetes, including macrovascular and microvascular diseases.
- To explore pharmacotherapies targeting diabetic endothelial dysfunction for improved therapeutic strategies.
Main Methods:
- This review synthesizes existing literature on diabetic vascular complications.
- Mechanisms of endothelial dysfunction are analyzed.
- Current and potential pharmacotherapies are discussed.
Main Results:
- Diabetes-induced risk factors trigger endothelial dysfunction, leading to atherosclerosis and basement membrane thickening.
- Endothelial dysfunction contributes significantly to morbidity and mortality in diabetic patients.
- Targeting endothelial dysfunction offers a promising avenue for managing diabetic vascular complications.
Conclusions:
- Understanding the mechanisms of endothelial dysfunction is crucial for developing effective treatments for diabetic vascular complications.
- Pharmacotherapies targeting endothelial dysfunction hold potential for early control of diabetes and its sequelae.
- Further research into therapeutic drug discovery is needed to accelerate effective treatments.
Abstract:
Diabetic vascular complications are prevalent and severe among diabetic patients, profoundly affecting both their quality of life and long-term prospects. These complications can be classified into macrovascular and microvascular complications. Under the impact of risk factors such as elevated blood glucose, blood pressure, and cholesterol lipids, the vascular endothelium undergoes endothelial dysfunction, characterized by increased inflammation and oxidative stress, decreased NO biosynthesis, endothelial-mesenchymal transition, senescence, and even cell death. These processes will ultimately lead to macrovascular and microvascular diseases, with macrovascular diseases mainly characterized by atherosclerosis (AS) and microvascular diseases mainly characterized by thickening of the basement membrane. It further indicates a primary contributor to the elevated morbidity and mortality observed in individuals with diabetes. In this review, we will delve into the intricate mechanisms that drive endothelial dysfunction during diabetes progression and its associated vascular complications. Furthermore, we will outline various pharmacotherapies targeting diabetic endothelial dysfunction in the hope of accelerating effective therapeutic drug discovery for early control of diabetes and its vascular complications.
Related Concept Videos
Diabetes: Symptoms, Diagnosis, and Complications
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...

